GGrantIndex
Sort

46,585 grants matching heart failure

Targeting GRK2 in the Heart

$396,250
Walter J Koch · Temple Univ Of The Commonwealth · R01 · FY2020 · HL

Project 1:Oxidant Stress and Cardiovascular Disease

$396,249
Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · P01 · FY2017 · HL

Project 1:Oxidant Stress and Cardiovascular Disease

$396,249
Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · P01 · FY2015 · HL

Project 1:Oxidant Stress and Cardiovascular Disease

$396,249
Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · P01 · FY2019 · HL

Mechanisms of mitochondrial calcium exchange in heart failure

$396,249
John William Elrod · Temple Univ Of The Commonwealth · R01 · FY2018 · HL

Project 1:Oxidant Stress and Cardiovascular Disease

$396,249
Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · P01 · FY2016 · HL

Project 1:Oxidant Stress and Cardiovascular Disease

$396,249
Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · P01 · FY2018 · HL

Targeting Nav1.5 trafficking as a therapy for lethal genetic cardiac arrhythmias

$396,248
Qing Kenneth Wang · Cleveland Clinic Lerner Com-Cwru · R01 · FY2015 · HL

Targeting Nav1.5 trafficking as a therapy for lethal genetic cardiac arrhythmias

$396,248
Qing Kenneth Wang · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · HL

Targeting Nav1.5 trafficking as a therapy for lethal genetic cardiac arrhythmias

$396,248
Qing Kenneth Wang · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · HL

cMyBP-C: Molecular Mechanisms of Actomyosin Modulation

$396,215
David M Warshaw · University Of Vermont & St Agric College · P01 · FY2011 · HL

Role of Renal Lymphatics in Blood Pressure Regulation

$396,201
Brett M Mitchell · Texas A&M University Health Science Ctr · R01 · FY2022 · DK

P2: Arhythmogenic Mechanisms

$396,166
Jose S Jalife · University Of Michigan At Ann Arbor · P01 · FY2008 · HL

Metabolomics Mapping and Cardiac Resynchronization

$396,158
Yong-Mei Cha · Mayo Clinic Rochester · R01 · FY2019 · HL

Metabolomics Mapping and Cardiac Resynchronization

$396,158
Yong-Mei Cha · Mayo Clinic Rochester · R01 · FY2020 · HL

Metabolomics Mapping and Cardiac Resynchronization

$396,158
Yong-Mei Cha · Mayo Clinic Rochester · R01 · FY2018 · HL

Primary and Tertiary Prevention of type 2 diabetes

$396,155
Robert Hanson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK

Influenza therapy by Au-nanorod 5'PPP-NS1-siRNA/cDNA targeting of bronchial cells

$396,117
Paul R Knight · State University Of New York At Buffalo · R21 · FY2010 · AI

The effect of voluntary bundled payments on vulnerable populations

$396,115
Amol S Navathe · University Of Pennsylvania · R01 · FY2021 · HS

Targeting Adiponectin for Cardioprotection in the Ischemic Heart

$396,101
Xin-Liang Ma · Thomas Jefferson University · R01 · FY2022 · HL

Chronic nicotine inhalation increases susceptibility to cardiovascular and pulmonary diseases through inhibition of local compensatory mechanisms

$396,097
Jason Davin Gardner · Lsu Health Sciences Center · R01 · FY2021 · HL

Regulation of BAR Function by localized P13K Inhibition

$396,040
Duke University · P01 · FY2005 · HL

Premotor control of upper airway and REM sleep atonia

$396,000
Leszek K Kubin · University Of Pennsylvania · R01 · FY2012 · HL

cMyBP-C: Molecular Mechanisms of Actomyosin Modulation

$395,975
David M Warshaw · University Of Vermont & St Agric College · P01 · FY2012 · HL

PSAT1 modified mRNA induces cardiac repair post-ischemic heart injury

$395,958
Ajit Magadum · Temple Univ Of The Commonwealth · R01 · FY2024 · HL